Never miss a post! Sign up for ML&P's mailing list by entering your information below. The list will only be used to inform you of new content (messages are sent approximately once a month).

Recent Posts

Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in patent law.

On 1 February 2019, article 53(3), second sentence of the Dutch Patent Act 1995 came into force introducing a patent exemption for the preparation...

Cystic Fibrosis Medicines Wars in Europe

Monday 4 February, the UK parliament will debate the issuing of a compulsory licence by the government, called ‘Crown use’, for the cystic fibrosis...

Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda

On Thursday 24 January, the World Health Organization’s 144th Executive Board meeting will kick off in Geneva. One of the agenda items is access...

Time to put a stop to the abuse of orphan drug regulation- the latest...

Today, the Dutch Medical Journal (Nederlands Tijdschrift voor Geneeskunde) reported on the case of lutetium-octreotaat, a cancer drug developed by researchers in the Dutch...

2018 Round-up of Noteworthy Medicines Law and Policy Events

We are reaching the end of 2018: Time for our end-of-the-year roundup of some significant developments in medicines law and policy. January The Chilean parliament started...